Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Gene Rank description Value Type Network Comparison Type Filtered Interaction Map green red network_comparison
Results: HTML CSV LaTeX Showing element 332 to 381 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1
Interaction Map: High confidence

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
332\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pleiotropic regulator 1 (prl1homolog, arabidopsis); pleiotropic regulator 1 (prl1, arabidopsis homolog). [source:refseq;acc:nm\_002669]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5975.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5051.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.183\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
333\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear matrix protein nmp200 related to splicing factor prp19. [source:refseq;acc:nm\_014502]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5961.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5039.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.18299\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
334\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
septin 4 (peanut-like protein 2) (brain protein h5) (cell division control-related protein 2) (hcdcrel-2) (bradeion beta) (ce5b3 beta) (cerebral protein-7) (hucep-7). [source:swissprot;acc:o43236]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
17655.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14924.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.18298\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
335\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable atp-dependent 61 kda nucleolar rna helicase (dead-box protein 21). [source:swissprot;acc:q9ny93]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4129.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3494.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.18181\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
336\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase epsilon p12 subunit (dna polymerase epsilon subunit 4). [source:swissprot;acc:q9nr33]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4431.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3751.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.18128\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
337\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c4 (hox-3e) (cp19). [source:swissprot;acc:p09017]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
24136.4\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
20446.1\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.18049\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
338\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-b4 (hox-2f) (hox-2.6). [source:swissprot;acc:p17483]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
339\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c5 (hox-3d) (cp11). [source:swissprot;acc:q00444]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
340\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c6 (hox-3c) (hho.c8) (cp25). [source:swissprot;acc:p09630]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
341\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-d4 (hox-4b) (hox-5.1) (hho.c13). [source:swissprot;acc:p09016]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
342\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-b5 (hox-2a) (hho.c10) (hu-1). [source:swissprot;acc:p09067]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
343\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-a5 (hox-1c). [source:swissprot;acc:p20719]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
344\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-a4 (hox-1d) (hox-1.4). [source:swissprot;acc:q00056]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
345\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
retinal short-chain dehydrogenase/reductase 3. [source:refseq;acc:nm\_016246]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
346\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
septin 1 (larp) (serologically defined breast cancer antigen ny-br- 24). [source:swissprot;acc:q8wyj6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
16780.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14229.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17931\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
347\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
enteropeptidase precursor (ec 3.4.21.9) (enterokinase). [source:swissprot;acc:p98073]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5885.09\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4991.02\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.17914\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
348\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 3b subunit 2 (spliceosome associated protein 145) (sap 145) (sf3b150) (pre-mrna splicing factor sf3b 145 kda subunit). [source:swissprot;acc:q13435]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
349\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative pre-mrna splicing factor rna helicase (deah box protein 15) (atp-dependent rna helicase #46). [source:swissprot;acc:o43143]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5554.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4714.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17806\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
350\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sedlin. [source:swissprot;acc:o14582]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
20483.9\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
17396.9\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.17745\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
351\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
synbindin (trs23 homolog) (hematopoietic stem/progenitor cell protein 172) (hspc172) (ptd009) (cgi-104). [source:swissprot;acc:q9y296]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
352\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bet3 homolog. [source:swissprot;acc:o43617]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
353\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
p66 alpha. [source:refseq;acc:nm\_017660]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
10911.1\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
12839\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.17669\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
354\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription repressor p66 beta component of the mecp1 complex. [source:refseq;acc:nm\_020699]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
355\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine aminotransferase (ec 2.6.1.5) (l-tyrosine:2-oxoglutarate aminotransferase) (tat). [source:swissprot;acc:p17735]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
356\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex protein 1, alpha subunit (tcp-1-alpha) (cct-alpha). [source:swissprot;acc:p17987]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12944.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11004.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1763\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
357\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
imp2 inner mitochondrial membrane protease-like; inner mitochondrial membrane peptidase 2 like. [source:refseq;acc:nm\_032549]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5950.22\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5061.11\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.17567\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
358\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microsomal signal peptidase 18 kda subunit (ec 3.4.-.-) (spase 18 kda subunit) (spc18) (endopeptidase sp18). [source:swissprot;acc:p21378]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
359\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 3 (ec 2.7.1.-). [source:swissprot;acc:q00526]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10887.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12798.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17559\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
360\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b2. [source:swissprot;acc:o95067]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10886\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12796.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17553\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
361\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 2 (ec 2.7.1.-) (p33 protein kinase). [source:swissprot;acc:p24941]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10880.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12787.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17528\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b1. [source:swissprot;acc:p14635]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10879.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12786.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17525\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
363\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division control protein 2 homolog (ec 2.7.1.-) (p34 protein kinase) (cyclin-dependent kinase 1) (cdk1). [source:swissprot;acc:p06493]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10876.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12780.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17509\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
364\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ptb domain adaptor protein ced-6; engulfment adapter protein. [source:refseq;acc:nm\_016315]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6088.47\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5189\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.17334\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
365\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcyphosine. [source:swissprot;acc:q13938]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
366\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
crooked neck-like protein 1 (crooked neck homolog) (hcrn) (cgi-201) (mstp021). [source:swissprot;acc:q9bzj0]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
367\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna polymerase epsilon, catalytic subunit a (ec 2.7.7.7) (dna polymerase ii subunit a). [source:swissprot;acc:q07864]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4719.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4024.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17268\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
368\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pre-mrna splicing factor prp17 (hprp17) (eh-binding protein 3) (ehb3). [source:swissprot;acc:o60508]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5959.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5082.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17261\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
369\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat-box-binding transcription factor (ccaat-binding factor) (cbf). [source:swissprot;acc:q03701]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4194.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3583.56\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17061\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
370\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lupus la protein (sjogren syndrome type b antigen) (ss-b) (la ribonucleoprotein) (la autoantigen). [source:swissprot;acc:p05455]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4808.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4108.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17058\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
371\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine protease htra2, mitochondrial precursor (ec 3.4.21.-) (high temperature requirement protein a2) (htra2) (omi stress-regulated endoprotease) (serine proteinase omi). [source:swissprot;acc:o43464]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5926.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5067.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16961\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
372\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable serine protease htra4 precursor (ec 3.4.21.-). [source:swissprot;acc:p83105]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5926.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5067\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16956\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
373\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable serine protease htra3 precursor (ec 3.4.21.-). [source:swissprot;acc:p83110]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5926.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5066.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16955\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
374\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine protease htra1 precursor (ec 3.4.21.-) (l56). [source:swissprot;acc:q92743]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5925.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5066.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16942\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm1 (small nuclear ribonuclear casm) (cancer-associated sm-like). [source:swissprot;acc:o15116]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5492.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4700.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16854\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
376\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
44050 protein. [source:refseq;acc:nm\_178832]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
14889.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
17385.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.16769\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
377\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear inhibitor of protein phosphatase-1 (nipp-1) (protein phosphatase 1, regulatory inhibitor subunit 8) [includes: activator of rna decay (ec 3.1.4.-) (ard-1)]. [source:swissprot;acc:q12972]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
378\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hira-interacting protein 5 (cgi-33). [source:swissprot;acc:q9ums0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
14561.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12471.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16758\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
379\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleoside-diphosphate reductase m2 chain (ec 1.17.4.1) (ribonucleotide reductase small chain). [source:swissprot;acc:p31350]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7811.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6704.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16512\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
380\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
acyl-coa dehydrogenase, very-long-chain specific, mitochondrial precursor (ec 1.3.99.-) (vlcad). [source:swissprot;acc:p49748]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
15138.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12998.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16461\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
381\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
multisynthetase complex auxiliary component p43 [contains: endothelial-monocyte activating polypeptide ii (emap-ii) (small inducible cytokine subfamily e member 1)]. [source:swissprot;acc:q12904]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6109.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5246.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16456\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/